Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

WY-8678

Known as: WY 8678, WY8678 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Bei unanästhesierten Ratten und Hunden wurden die antihypertensiven Eigenschaften von 2,6-Dichlorobenzyliden-Aminoguanidin-Azetat… Expand
  • table I
  • table II
  • figure 1
Is this relevant?
1982
1982
The general pharmacological properties of guanabenz (Wy-8678), a new centrally acting antihypertensive agent, on the central… Expand
Is this relevant?
1982
1982
Guanabenz (WY-8678) was given to rats to examine its effects on their reproductive ability, dams and their fetuses. The drug was… Expand
Is this relevant?
1982
1982
Guanabenz (WY-8678) was given to pregnant rats to examine its effects on dams, their fetuses, and offspring. The drug was… Expand
Is this relevant?
1981
1981
The pharmacokinetics of guanabenz (E-2,6-dichlorobenzylidene aminoguanidine acetate, Wy-8678) in rhesus monkeys given 14C-labeled… Expand
Is this relevant?
1980
1980
The antihypertensive agent guanabenz (E-2,6-dichlorobenzylidene aminoguanidine acetate. Wy-8678) was administered i.v. in single… Expand
Is this relevant?
1970
1970
Wy-8678 has been shown to lower blood pressure and heart rate in unanesthetized hypertensive animals. The present study describes… Expand
Is this relevant?
1970
1970
Abstract Wy-8678 (2,6-dichlorobenzylidene amino guanidine acetate) has recently been shown to reduce blood pressure in… Expand
Is this relevant?